Physician

Ingrid Lidia Roig, M.D

According to 2025 Medicare claims, Ingrid Roig, M.D (NPI: 1881847002) practices infectious disease in the Huntsville, AL market, with the plurality of this provider's patient population coming from Madison, AL. This provider's primary affiliated billing organization is METRO INFECTIOUS DISEASE CONSULTANTS, LLC (NPI: 1235125717; TIN: 363966745) and primary practice location at 35801-5029. Roig is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Roig's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 546 traditional Medicare patients, billed 58,195 HCPCS/CPT codes, and received $1,164,320 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,006 prescription claims across 177 beneficiaries totaling $701,997 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). 2021 DME data shows 42 claims. Open Payments data shows 4 records totaling $315. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $474,251 to $1,164,320. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,125 to $1,099.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	662	137,151	$474,251
2016	565	38,214	$378,794
2017	615	78,968	$427,843
2018	622	49,366	$891,675
2019	572	65,912	$1,209,748
2020	693	65,571	$2,336,763
2021	631	94,371	$1,558,948
2022	657	131,170	$1,419,232
2023	653	129,917	$1,554,138
2024	546	58,195	$1,164,320

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	143	869	$655,246
2016	108	706	$590,667
2017	118	646	$502,269
2018	133	882	$446,757
2019	130	697	$434,243
2020	143	886	$511,089
2021	147	854	$710,298
2022	140	906	$858,558
2023	178	1,118	$639,724
2024	177	1,006	$701,997

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$896
2016	N/R	N/R	N/R
2017	N/R	12	$1,568
2018	N/R	11	$1,440
2019	N/R	111	$41,311
2020	N/R	108	$44,773
2021	N/R	42	$19,122
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	206	216	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	99	186	$86
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	277	932	$85
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	97	303	$42
36415	Insertion of needle into vein for collection of blood sample	45	59	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	37	1,110	$141,996
Vibativ	Telavancin Hcl	21	136	$121,164
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	12	360	$45,583
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	12	360	$42,779
Isentress	Raltegravir Potassium	13	390	$29,593

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$315	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ingrid Lidia Roig, M.D?

Tedicare shows public-source Medicare data for Ingrid Lidia Roig, M.D (NPI 1881847002), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ingrid Lidia Roig, M.D have ACO affiliation data?

Ingrid Lidia Roig, M.D is shown with ACO affiliation data for American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Ingrid Lidia Roig, M.D?

Ingrid Lidia Roig, M.D is linked to METRO INFECTIOUS DISEASE CONSULTANTS, LLC (billing NPI 1235125717) in the available physician profile data.

Does Ingrid Lidia Roig, M.D have Open Payments data?

Ingrid Lidia Roig, M.D has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.